Team:Imperial/EColi

From 2014.igem.org

(Difference between revisions)
Line 82: Line 82:
                     <section id="Aims">
                     <section id="Aims">
                         <h2>Aims</h2>
                         <h2>Aims</h2>
-
                         <figure class="content-image image-right">
+
                          
-
                            <img class="image-full" src="https://static.igem.org/mediawiki/2014/f/fe/IC14-ecoli-fig2.png">
+
-
                            <figcaption>Figure 3</figcaption>
+
-
                        </figure>
+
                         <p>By transferring the cellulose production operon from its native organism <em>Gluconacetobacter xylinus</em> into the lab-friendly strain <em>Escherichia coli</em>, we aim to emphasize the importance of increasing cellulose production per unit time to achieve a reduction in pellicle growth timeframe and production costs. We also aim to optimize growth conditions by allowing for higher (and more competitive) temperatures and shaking conditions, and to ease genetic engineering and cloning procedures due to the wider availability of functional, already characterized Biobricks to work with cellulose.</p>
                         <p>By transferring the cellulose production operon from its native organism <em>Gluconacetobacter xylinus</em> into the lab-friendly strain <em>Escherichia coli</em>, we aim to emphasize the importance of increasing cellulose production per unit time to achieve a reduction in pellicle growth timeframe and production costs. We also aim to optimize growth conditions by allowing for higher (and more competitive) temperatures and shaking conditions, and to ease genetic engineering and cloning procedures due to the wider availability of functional, already characterized Biobricks to work with cellulose.</p>
Line 111: Line 108:
                         <figure class="content-image">
                         <figure class="content-image">
                             <img class="image-full" src="https://static.igem.org/mediawiki/2014/5/55/IC14-ecoli-pBAD-pLAC-CD.png">
                             <img class="image-full" src="https://static.igem.org/mediawiki/2014/5/55/IC14-ecoli-pBAD-pLAC-CD.png">
-
                             <figcaption>Figure 4: pSB-pBAD-AB and pLAC-CD</figcaption>
+
                             <figcaption>Figure 3: pSB-pBAD-AB and pLAC-CD</figcaption>
                         </figure>
                         </figure>
                         <figure class="content-image image-right">
                         <figure class="content-image image-right">
                             <img class="image-full" src="https://static.igem.org/mediawiki/2014/e/e7/IC14-ecoli-ABCDfragments.jpg.png">
                             <img class="image-full" src="https://static.igem.org/mediawiki/2014/e/e7/IC14-ecoli-ABCDfragments.jpg.png">
-
                             <figcaption>Figure 5: acsABCD fragments</figcaption>
+
                             <figcaption>Figure 4: acsABCD fragments</figcaption>
                         </figure>
                         </figure>
                         <p>With this approach, we allow for our system to be implemented in new range of hosts because a larger set of growth conditions, inducer concentrations and growth phases can be tested in order to achieve the required stoichiometry for the system to become functional.</p>
                         <p>With this approach, we allow for our system to be implemented in new range of hosts because a larger set of growth conditions, inducer concentrations and growth phases can be tested in order to achieve the required stoichiometry for the system to become functional.</p>
Line 125: Line 122:
                         <figure class="content-image image-small">
                         <figure class="content-image image-small">
                             <img class="image-full" src="https://static.igem.org/mediawiki/2014/f/ff/IC14-ecoli-AB-CD-constructs.png">
                             <img class="image-full" src="https://static.igem.org/mediawiki/2014/f/ff/IC14-ecoli-AB-CD-constructs.png">
-
                             <figcaption>Figure 6: acsAB and acsCD constructs</figcaption>
+
                             <figcaption>Figure 5: acsAB and acsCD constructs</figcaption>
                         </figure>
                         </figure>
Line 179: Line 176:
                                         </tr>
                                         </tr>
                                     </table>
                                     </table>
-
                                     <figcaption>List of antibiotics used, in relation to their respective constructs</figcaption>
+
                                     <figcaption>Figure 6: List of antibiotics used, in relation to their respective constructs</figcaption>
                                 </figure>
                                 </figure>
Line 366: Line 363:
                             </div>
                             </div>
                             <h3>Characterising Cellulose Production</h3>
                             <h3>Characterising Cellulose Production</h3>
 +
<div>
 +
<figure class="content-image image-right">
 +
                            <img class="image-full" src="https://static.igem.org/mediawiki/2014/f/fe/IC14-ecoli-fig2.png">
 +
                            <figcaption>Figure 3</figcaption>
 +
                        </figure>
 +
</div>
-
                            <div class="accordion">
 
-
                                <h3>Preliminary Characterization: Congo Red Assay</h3>
 
-
                                <div>
 
-
                                    <figure class="content-image image-right image-small">
 
-
                                        <img class="image-full" src="https://static.igem.org/mediawiki/2014/b/b5/IC14-ecoli-congo-assay.jpg">
 
-
                                        <figcaption>Figure 2</figcaption>
 
-
                                    </figure>
 
-
                                </div>
 
-
                                <h3>Data Analysis</h3>
 
-
                                <div>
 
-
                                </div>
 
-
                            </div>
 
                     </section>
                     </section>
                     <section id="future">
                     <section id="future">

Revision as of 01:51, 18 October 2014

Imperial iGEM 2014

E. coli

Overview

Escherichia coli is a very unfussy strain. It is able to grow under a diverse range of conditions, it is very well understood, easy to engineer and there are numerous parts, control circuits, biological manufacturing platforms and various other complex constructs proven functional in this host. For these and other reasons, it is widely used in the Synthetic Biology community as a cloning host and for various other purposes.

However, some Escherichia coli strains only produce cellulose at a specific set of phenotypical conditions (its secretion is generally linked to biofilm formation and stress situations). In order to encourage the use of bacterial cellulose as a functional, modular biomaterial that can become easy, cheap and quick to produce, it is necessary for its corresponding production machinery to be implemented in organisms that are easier and quicker to grow in manufacturing plants and bioreactors.

Here, we confirm that the cellulose production machinery can be transferred into other organisms. We have proven portability of the Acs cellulose operon in Escherichia coli using Congo Red binding assays.

Key Achievements

  • We have contributed significantly to the Registry of Standard Parts by providing the necessary components for the assembly of a 10kB operon for cellulose production in a wide range of organisms.
  • We have proven system portability by transferring the cellulose production machinery from Gluconacetobacter xylinus into Escherichia coli and demonstrating its functionality in the latter.
  • Assembled a fully synthetic, functional, cellulose-producing system in Escherichia coli without engineering signal peptides, indicating that these and the signal peptides of G. xylinus must be of high similarity.
  • We were able to successfully set up working stoichiometry and ratios of expression of the operon genes in E. coli that can be fine tuned. This ensures proper protein folding, complex assembly and correct levels of activity of each of the parts in the process of making cellulose.
  • In summary, we have majorly contributed to the Synthetic Biology community by encouraging the implementation of non-native, complex functions and systems into new hosts and by encouraging the production and uses of bacterial cellulose by a broader range of hosts to widen the applications of such useful biomaterial.

Figure 1
Figure 2

Aims

By transferring the cellulose production operon from its native organism Gluconacetobacter xylinus into the lab-friendly strain Escherichia coli, we aim to emphasize the importance of increasing cellulose production per unit time to achieve a reduction in pellicle growth timeframe and production costs. We also aim to optimize growth conditions by allowing for higher (and more competitive) temperatures and shaking conditions, and to ease genetic engineering and cloning procedures due to the wider availability of functional, already characterized Biobricks to work with cellulose.

Engineering

The cellulose production operon in Gluconacetobacter xylinus is a 10kb genomic region, consisting of four main elements:

  • acsAB, known as cellulose synthase, is made up of two domains: acsA being the catalytic domain, and acsB being the cyclic-di-GMP-binding domain. This modular enzyme requires the second messenger cyclic-di-GMP in order to carry out efficient catalysis.
  • acsC codes for an oligomeric element that gets embedded in the extracellular membrane and allows transport of the growing polymer across the cell membrane into the extracellular environment.
  • acsD is believed to be a non-essential element, although it is a key player in the control of cellulose crystallinity and required for maximal cellulose productivity.

The native operon is highly regulated at transcriptional, translational and post-translational levels. Cellulose production responds to a wide set of internal signals and environmental cues. The native ribosomal binding sites (RBS) are predicted to be weak by translation rate calculators (The Salis Lab RBS calculator and Postech UTR designer ). This is perhaps to reduce noise in gene expression (strong promoter, weak RBS is less noisy that weak promoter strong RBS). The promoter region has not yet been characterized in Gluconacetobacter xylinus, however.

The first step of our computational design engineering was to identify the coding sequences and extract them from NCBI. We removed some native regulation by codon-optimizing the sequences for expression in E.coli and replaced the native RBS’s with the strong B0034 sequence. The 6 base pairs either side of the B0034 RBS were edited with the Salis Lab RBS calculator design function to tune RBS strength output to better preserve the natural stoichiometry.

Finally, in order to allow for even more customizable fine-tuning of the system, the operon was divided and cloned into two separate expression vectors: the AcsAB element was cloned under the control of the inducible pBAD promoter contained within pSB1C3, a high copy plasmid that would contribute to higher expression of Cellulose Synthase. Alternatively, AcsC and AcsD, believed to be expressed at lower levels in G.xylinus, was put under the control of the pLAC promoter and was transferred into a low copy plasmid, pSB3K3 so as to maintain lower levels of expression. This approach provided the following advantages:

  • Reducing the size of the final expression vector avoids complications during assembly and vector take-up, and it also prevents a large construct from becoming a burden for cell growth and vector propagation.
  • By expressing the cellulose production machinery from two separate expression vectors, the following levels of control become available to us: the first being the changes in vector copy number, which directly affects gene expression levels throughout induction, and the second being the ability to activate the system using two different inducers. These key features of our system allow for a larger scope for fine-tuning and optimization of cellulose production levels.
Figure 3: pSB-pBAD-AB and pLAC-CD
Figure 4: acsABCD fragments

With this approach, we allow for our system to be implemented in new range of hosts because a larger set of growth conditions, inducer concentrations and growth phases can be tested in order to achieve the required stoichiometry for the system to become functional.

In order to ease synthesis, the operon sequence was split into 4 fragments of similar sizes. We took advantage of the presence of two restriction sites: An NcoI present within the AcsAB sequence, and a PvuII site contained within AcsC. Furthermore, the BioBrick prefix and suffix were included and any additional sites removed elsewhere.

By standard cloning, these fragments could easily be put together to yield the following constructs:

Figure 5: acsAB and acsCD constructs

Gene Designer served as a very useful tool for assembling constructs and predicting cloning outcomes before proceeding with the experimental procedure. Find above the plasmid maps of our resulting constructs, and refer to Materials and Methods for a deeper insight into the assembly process.

Materials and Methods

1.0 Cell Strains and Media Components

Escherichia coli strain DH10B were made chemically competent following a standard protocol and were used to clone the pSB-AraC-pBAD and pSB-LacI-pLAC elements. Additionally, High Efficiency chemically competent DH10B Escherichia coli were purchased from New England Biolabs for assembly of the Acs cellulose-producing operon, which was codon-optimized for expression in E.coli and synthesized by GeneArt. Both strains were grown overnight in liquid cultures (supplemented with specific antibiotics), or on semi-solid LB-Agar plates, provided with the specific antibiotic, as listed on the table below.

Luria Broth Miller (LB) and LB Agar were purchased from VWR, prepared using standard protocols and used throughout the experimental procedure. During characterization, Acs-containing strains were supplemented with 1% D-glucose, 0.1% Arabinose and 0.5mM IPTG.

Plasmid name Vector backbone Antibiotic concentration (ug/ml)
pSB-AraC-pBAD pSB1C3 Chloramphenicol 50
pSB-LacI-pLAC pSB3K3 Kanamycin 25
pSB-AcsAB pSB1C3 Chloramphenicol 50
pSB-AcsCD pSB1C3 Chloramphenicol 50
pSB-AraC-pBAD-AcsAB pSB1C3 Chloramphenicol 50
pSB-LacI-pLAC-CD pSB3K3 Kanamycin 25
Figure 6: List of antibiotics used, in relation to their respective constructs

2.0 Chemicals

Congo Red was purchased from Sigma Aldrich (Steiheim, Germany) and diluted in 1x PBS to a concentration of 350 uM. The final Congo Red concentration used during system characterization steps was 20 uM. This was also used, also at a concentration of 20 uM, to make LB Agar Congo Red Assay plates.

3.0 Construct Assembly

3.1 Cloning of pSB-AraC-pBAD

The AraC and pBAD elements were obtained by PCR, using the Biobricks BBa_K325108, BBa_K325218 and BBa_K325219 as DNA templates, all of which follow the standard structure showed on figure 7. The primers used during this procedure were as follows:

  • Forward: TACTAGTAGCGGCCGCTGCAG
  • Reverse: GCTAGCCCAAAAAAACGGGTATGGAG
Figure 7 - Plasmid maps describing both the original (left) and engineered (right) AraC-pBAD-containing parts, including all relevant elements. These were designed and cloned in silico on GeneDesigner.

The amplified elements were DpnI-treated following a standard procedure (New England Biolabs), and were subsequently submitted to a purification step (Qiaquick PCR clean up, Qiagen) prior to self-ligation. Three different template concentrations were tested during ligation (specifically 3 ng, 7.5 ng and 15 ng), and were incubated at room temperature for 1h+. The ligation mix was then transformed into chemically competent DH10B Escherichia coli using a standard chemical transformation protocol and plated out on Chloramphenicol-specific LB plates.

3.2 Cloning of pSB-LacI-pLAC

3.3 Assembly of AcsAB and AcsCD

Figure 8:

The AcsABCD operon was designed in silico as described in the previous section. It was ordered for synthesis at GenArt in the form of four separate elements of similar sizes, named AcsA, AcsB, AcsC and AcsD, respectively. After synthesis, the constructs were directly transformed into DH10B E.coli using a standard chemical transformation protocol and plated overnight supplied with 50 ug/ml Kanamycin. 5ml LB were inoculated with a freshly growing colony and grown overnight at 37 C, under shaking conditions. Glycerol stocks were produced prior to proceeding with the assembly process.

In order to meet the Registry standards, we aimed to clone these elements into pSB1C3. To do so, we proceeded as described on figure 8. Two separate rounds of digestion were carried out using EcoRI, NcoI, PvuII and PstI to, and the resulting fragments (AcsA, AcsB, AcsC and AcsD and linearized pSB1C3) were submitted to a three-part ligation after dephosphorylation of the vector backbone (rAPid desphosphorylation, Roche). An equimolar ratio amongst all three parts was established during the ligation procedure, which in turn proceeded at 4 degrees overnight. The NEB High Efficiency Transformation protocol was used on NEB 10B cells (New England Biolabs) to propagate the resulting plasmid. Transformed cells were plated and incubated overnight at 37 C. 5 ml LB supplied with 50 ug/ml Chloramphenicol were inoculated with a selection of colonies for further analysis (refer to Results for additional information).

3.4 Assembly of pSB-AraC-pBAD-AcsAB

AcsAB was cloned into pSB-AraC-pBAD by Biobrick cloning. The destination vector was linearized using SpeI and PstI (New England Biolabs), and AcsAB (previously digested with XbaI and PstI, and gel extracted using the Minelute Gel Extraction Kit, by Qiagen) was ligated at a 1:1 ratio throughout an overnight ligation at room temperature. The resulting part was transformed into chemically competent DH10B Escherichia coli and plated on LB Agar+Chloramphenicol plates, grown overnight at 37 C. 5 ml LB falcons supplied with 50 ug/ml Chloramphenicol were inoculated with a selection of freshly grown colonies for further restriction analysis (refer to Results for additional information)

3.5 Assembly of pSB-LacI-pLAC-CD

Similarly to 3.4, AcsCD was cloned by BioBrick cloning into the pSB3K3 low copy expression vector containing the LacI-pLAC regulatory elements. Vector and insert were ligated at a 1:1 ratio overnight at room temperature. After transformation and plating on LB Agar+Kanamycin (25 ug/ml), colonies were screened by Greentaq colony PCR, and were further confirmed during the Congo Red Assay.

Electroporation of pSB-pLAC-CD into electrocompetent AcsAB-containing DH10B cells

DH10B E.coli already containing the AcsAB construct were made electrocompetent using a standard protocol, which can be found in the Protocols section. A second round of transformation was carried to insert pLAC-AcsCD. 5ul of miniprepped pSB-pLAC-CD (diluted in ddH2O) were added into 50ul electrocompetent DH10B cells already containing the pBAD-inducible AcsAB element. Electroporation was carried out in in 10mm electrocuvettes at 1.8 kV, 200 Ohm resistance and 25 mF capacitance. 500ul SOC medium was added to the electroporated samples and these were recovered at 37 °C for 1h before plating on Kanamycin25 + Chloramphenicol 50 LB Agar plates.

Congo Red Characterization

LB Agar Congo Red assay plates were prepared with a final Congo Red concentration of 20uM, and they were supplied with 0.1% Arabinose, 0.5mM IPTG, 50 ug/mL Chloramphenicol, 25 ug/mL Kanamycin and 1% Glucose. Transformed cells containing both AcsAB and AcsCD were plated on Congo Red assay plates and incubated at 37 °C. They were qualitatively assayed after 24h and 48h for cellulose production. Finally, 5 mL LB supplied with 0.1% Arabinose, 0.5mM IPTG, 50 ug/mL Chloramphenicol, 25 ug/mL Kanamycin and 1% Glucose were inoculated with freshly grown, cellulose-producing colonies and were grown for 16h at 30 °C, 180 rpm. An empty vector control was also grown overnight for comparative analysis. These liquid cultues were supplied with Congo Red, to yield a final concentration of 20uM. They were incubated under static conditions for 2h at room temperature, and were later pelleted down to allow for qualitative analysis of Congo Red binding.

AcsAB functionality was assayed by inducing AcsAB-containing cells with 0.1% Arabinose in 5mL LB supplied with 1% Glucose and Chloramphenicol. Overnight incubations were set up at 30 °C and 37 °C, and both empty vector controls and un-induced controls were also assayed. Cells were pelleted at 4000rpm for 10 minutes and the supernatant was kept for further analysis. Cells were resuspended in 1xPBS and sonicated for 3 minutes as on/off cycles of 15 seconds. Both the membrane and soluble samples produced after centrifugation were kept for further analysis. Congo Red was then added to the LB, soluble and membrane samples up to a final concentration of 20uM, and no Congo Red samples were also kept for further inspection. Samples were incubated for 2h at static conditions and at room temperature to allow for Congo Red binding. 96-well plates were inoculated for further absorbance measurements at 490nm.

Results

Constructs

All constructs were assembled as described in Materials and Methods. As a preliminary verification step, restriction analyses were carried out using the corresponding restriction enzymes (refer to figure legends for more details) and results were visualized on 0.7-1% agarose gels. Final confirmation was obtained by gene sequencing, during which the BioBrick Verification Primers and walking primers were used. These are shown on the table below, please refer to the Registry for further information.

pSB-AraC-pBAD Forward: TACTAGTAGCGGCCGCTGCAG
Reverse: GCTAGCCCAAAAAAACGGGTATGGAG
BioBrick Verification Primers Forward: TGCCACCTGACGTCTAAGAA
Reverse: ATTACCGCCTTTGAGTGAGC
Walking Primer 1 TCT GAA TTA TGC CAT TGG TCA TAC CG
Walking Primer 2 ATA TGT TTC ATG CAG TTG GCA CC
Walking Primer 3 GAT GCA TGG GTT GAT TGG GG
Walking Primer 4 ATC CAG CAC ATC CGA CCT TTG
Walking Primer 5 GTT ACC GCA AGT AAA CTG CAA G
Walking Primer 6 GAT GGT CTG ATT CGT CTG GTT A
Walking Primer 7 ACG CAG CAC AGG TCA GAC CGG TGA A
Walking Primer 8 ATA TTG ATC TGA CCA CCG AACA
Walking Primer 9 TGC ACC GCC TGG TGA AAA TGG TT
Walking Primer 10 GTG GCT ATG CAA TTC AGA CAG GT
Walking Primer 11 TTC ATT CCC AGC GGT CGG TCG AT
Walking Primer 12 GTT TGC GTG GTG ATC TTT TT
Figure 9 - List of primers used by Team E.coli during the experimental procedure
Figure 10: pSB-AcsAB
Figure 11: pSB-AcsCD
Figure 12: pSB-AraC-pBAD
Figure 13: pSB-AraC-pBAD-AcsAB and pSB-LacI-AcsAB
Figure 14: pLAC-AcsCD colony PCR results. Further details on the procedure can be found on the Methods and Materials section. Those colonies that we testes further have been highlighted with numbers on the pictures. Specifically, colony A1 was used for subcloning into AcsAB containing E.coli DH10B. Plates A and B were generated
Figure 15: pLAC-AcsCD colony PCR results. Further details on the procedure can be found on the Methods and Materials section. Those colonies that we testes further have been highlighted with numbers on the pictures. Specifically, colony A1 was used for subcloning into AcsAB containing E.coli DH10B. Plates A and B were generated

Characterising Cellulose Production

Figure 3

Future Work

References